These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17489969)

  • 21. The prescribed duration algorithm: utilising 'free text' from multiple primary care electronic systems.
    Brooks CJ; Lyons RA; Jones KH; Hutton AJ; Walker R; Evans KA; Lloyd K; Ford DV
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):983-9. PubMed ID: 20652870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple comparisons with a control in families with both one-sided and two-sided hypotheses.
    Cheung SH; Kwong KS; Chan WS; Leung SP
    Stat Med; 2004 Oct; 23(19):2975-88. PubMed ID: 15351956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Step-up testing procedure for multiple comparisons with a control for a latent variable model with ordered categorical responses.
    Lin Y; Kwong KS; Cheung SH; Poon WY
    Stat Med; 2014 Sep; 33(21):3629-38. PubMed ID: 24757077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natalizumab: bound to rebound?
    Schiess N; Calabresi PA
    Neurology; 2009 Feb; 72(5):392-3. PubMed ID: 19188569
    [No Abstract]   [Full Text] [Related]  

  • 25. Testing homogeneity of two zero-inflated Poisson populations.
    Tse SK; Chow SC; Lu Q; Cosmatos D
    Biom J; 2009 Feb; 51(1):159-70. PubMed ID: 19219907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple imputation methods for multivariate one-sided tests with missing data.
    Wang T; Wu L
    Biometrics; 2011 Dec; 67(4):1452-60. PubMed ID: 21466531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the assessment of dose proportionality: a comparison of two slope approaches.
    Cheng B; Chow SC; Su WL
    J Biopharm Stat; 2006 May; 16(3):385-92. PubMed ID: 16724492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of extensions of bivariate rank sum statistics to the crossover design to compare two treatments through four sequence groups.
    Kawaguchi A; Koch GG; Ramaswamy R
    Biometrics; 2009 Sep; 65(3):979-88. PubMed ID: 19173698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gatekeeping procedures with clinical trial applications.
    Dmitrienko A; Tamhane AC
    Pharm Stat; 2007; 6(3):171-80. PubMed ID: 17583553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methodologically sound, cost-effective research on the outcome of couple therapy.
    Christensen A; Baucom DH; Vu CT; Stanton S
    J Fam Psychol; 2005 Mar; 19(1):6-17. PubMed ID: 15796648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sample size calculations for 3-level cluster randomized trials.
    Teerenstra S; Moerbeek M; van Achterberg T; Pelzer BJ; Borm GF
    Clin Trials; 2008; 5(5):486-95. PubMed ID: 18827041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testing for ordered group effects in binary and continuous outcomes.
    Farrell PJ; Park CG
    Biom J; 2007 Aug; 49(4):585-98. PubMed ID: 17634976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lessons from randomised direct comparative trials.
    Achiron A; Fredrikson S
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S19-24. PubMed ID: 19200860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On identification of the number of best treatments using the Newman-Keuls test.
    Wu SS; Wang W; Annis DH
    Biom J; 2008 Oct; 50(5):861-9. PubMed ID: 18932144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Confidence regions for Bonferroni-based closed tests extended to more general closed tests.
    Guilbaud O; Karlsson P
    J Biopharm Stat; 2011 Jul; 21(4):682-707. PubMed ID: 21516564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing the order of hypotheses in serial testing of multiple endpoints in clinical trials.
    Zhang Z; Wang C; Troendle JF
    Stat Med; 2015 Apr; 34(9):1467-82. PubMed ID: 25620627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artificial neural network prediction of clozapine response with combined pharmacogenetic and clinical data.
    Lin CC; Wang YC; Chen JY; Liou YJ; Bai YM; Lai IC; Chen TT; Chiu HW; Li YC
    Comput Methods Programs Biomed; 2008 Aug; 91(2):91-9. PubMed ID: 18508152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evidence provided by a single trial is less reliable than its statistical analysis suggests.
    Borm GF; Lemmers O; Fransen J; Donders R
    J Clin Epidemiol; 2009 Jul; 62(7):711-715.e1. PubMed ID: 19171462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
    Katz J; Finnerup NB; Dworkin RH
    Neurology; 2008 Jan; 70(4):263-72. PubMed ID: 17914067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commentary: multilevel endpoints and the problems of theoretical aggregation and overlapping.
    Adamiak GT
    J Clin Epidemiol; 2008 Feb; 61(2):198-9; author reply 199-201. PubMed ID: 18177794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.